📈 SSRM, MRNA, PARR lead biggest stock gainers today — median intraday gain ~11.4%, market movers & stocks breaking out | March 5, 2026
SSRM, MRNA, PARR made moves today. Here's what you need to know.
Top Picks
Disclaimer: This AI-generated analysis is for educational and informational purposes only. It does not constitute financial advice. Always do your own research and consult with a licensed financial advisor before making investment decisions.
Market Overview
Key Observation
The data suggests a broad short‑term buying interest with a median intraday gain of ~11.4% and multiple names trading at or near 52‑week highs. Strength is concentrated in individual momentum and breakout candidates while a notable subset are low in their 52‑week ranges.
Volume Analysis
The data suggests mixed volume confirmation: median volume spike is ~1.5x, with clear volume leaders (WIX 3.30x, SSRM 2.93x, BOX 2.63x, COIN 2.47x, DNTH 2.09x) validating some moves, but many names show only modest volume uplift (around 1.2–1.9x) or below‑average activity.
Top PicksShowing 2 of 5
SSRM
Analysis
The data suggests SSRM displays the strongest combination of price breakout (range_position 99.1) and solid momentum (momentum_score 65) with a sizable volume spike (2.93x) and quality valuation metrics (PE 18.0, PB 1.9). Market cap is meaningful ($6.76B) and the stock sits at a 52‑week high region, indicating institutional/sector interest. Uptrend tag reinforces trend continuation potential over short term.
Key Metrics
change_pct 14.97%, range_position 99.1, volume_ratio 2.93
Risk Factors
Near‑highs may attract profit‑taking; commodity/sector volatility can reverse gains.
Suggested Action
The data suggests monitoring for sustained volume above the 2x level and price holding above the recent high; consider evaluating entries on pullbacks to near recent breakout support and use defined risk controls.
MRNA
Analysis
The data suggests Moderna is at a high range_position (95.3) with a strong intraday gain (15.99%) and near‑2x volume (1.96x), indicating a momentum breakout by an unprofitable growth name with high market cap ($22.83B). Momentum_score 60 and 'Speculative Momentum' tag indicate trend interest but the 'Unprofitable' valuation and lack of PE require caution. Analyst consensus is Hold, suggesting mixed fundamental sentiment.
Key Metrics
change_pct 15.99%, range_position 95.3, volume_ratio 1.96
Risk Factors
Unprofitable valuation and analyst Hold rating could lead to sharp reversals on news or profit taking.
Suggested Action
The data suggests watching volume sustain above ~1.5x and price remain above the current breakout level; consider short‑term momentum engagements with tight risk controls and defined exit levels.
+3 more top picks available
Sign up free to unlock all picks
Unlock Full Analysis
Sign up for free to access the complete Gainers Cockpit analysis
You're missing out on:
By signing up, you agree to our Terms of Service and Privacy Policy